Skip to main content
Fig. 1 | Arthritis Research & Therapy

Fig. 1

From: Detecting gastrointestinal manifestations in patients with systemic sclerosis using anti-gAChR antibodies

Fig. 1

Schematic representation of study design. Details regarding study design and recruitment for patients in each group. We tested sera from patients with SSc. Using the LIPS assay, we detected autoantibodies against gAChR in 21% (4 of 19) of samples from patients with SSc and GI manifestations, and in 10% (3 of 31) of samples from patients with patients without GI manifestations

Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us